CAS: 1195765-45-7 - Dabrafenib
Fórmula:C23H20F3N5O2S2
InChI:InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)
Chave InChI:InChIKey=BFSMGDJOXZAERB-UHFFFAOYSA-N
SMILES:O=S(=O)(NC=1C=CC=C(C1F)C=2N=C(SC2C=3N=C(N=CC3)N)C(C)(C)C)C=4C(F)=CC=CC4F
- Sinónimos:
- Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-
- Dabarefenib
- Dabrafenib
- Debrafenib free base
- Gsk 2118436
- Gsk 436
- N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
- N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
- Tafinlar
- Tafmlar
- Ver mais sinónimos
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Dabrafenib REF: 4Z-D-108001CAS: 1195765-45-7 | - - - | A consultar | Qui 02 Jan 25 | |
Dabrafenib REF: 7W-GP7467CAS: 1195765-45-7 | - - - | A consultar | Qui 02 Jan 25 | |
Dabrafenib REF: TM-T1903CAS: 1195765-45-7 | 100% - 99.83% | 48,00 €~153,00 € | Ter 07 Jan 25 | |
Dabrafenib REF: 3D-FA65034CAS: 1195765-45-7 | Min. 95% | 164,00 €~457,00 € | Seg 13 Jan 25 | |
Dabrafenib REF: TR-D101000CAS: 1195765-45-7 | - - - | 140,00 €~457,00 € | Seg 10 Fev 25 |
Ref: 4Z-D-108001
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Ref: 7W-GP7467
Tamanho indefinido | A consultar |
Dabrafenib
Ref: TM-T1903
5mg | 48,00 € | ||
10mg | 62,00 € | ||
25mg | 78,00 € | ||
50mg | 92,00 € | ||
100mg | 113,00 € | ||
200mg | 153,00 € | ||
1mL*10mM (DMSO) | 51,00 € |
Dabrafenib
Ref: 3D-FA65034
10mg | 164,00 € | ||
25mg | 201,00 € | ||
50mg | 228,00 € | ||
100mg | 325,00 € | ||
250mg | 457,00 € |
Dabrafenib
Ref: TR-D101000
Ea | 330,00 € | ||
10mg | 140,00 € | ||
50mg | 457,00 € |